Last reviewed · How we verify
NCT05309538
Paroxysmal Positional Vertigo & Repositioning Maneuvers
NA trial testing Modified eply & Semont maneuver in Benign Paroxysmal Positional Vertigo in 90 participants. Completed in 1 January 2022.
1 January 2022
Quick facts
| Lead sponsor | Neuro Counsel Hospital, Pakistan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 2 January 2021 |
| Primary completion | 1 January 2022 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Modified eply & Semont maneuver
- betahistine & Modified eply & Semont maneuver
Conditions studied
- Benign Paroxysmal Positional Vertigo — all drugs for Benign Paroxysmal Positional Vertigo →
Sponsor
Neuro Counsel Hospital, Pakistan
Who can join
Adults 18 to 60, any sex, with Benign Paroxysmal Positional Vertigo. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
: Benign Paroxysmal Positional Vertigo is a condition related to vestibular system accompanied by dizziness, tinnitus and balance problems leading to increased fall risk and potential disability. Various treatment options are available including pharmacotherapy and vestibular rehabilitation with varied results
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05309538
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Benign Paroxysmal Positional Vertigo
Currently open trials in the same condition.
- NCT06738823 — Effect of Wii Fit Training in Comparison to Vestibular Rehabilitation Training on Balance in Patients With Benign Paroxy · NA · recruiting
- NCT06725966 — Personalized Treatment of Refractory BPPV · NA · recruiting
- NCT06001047 — Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV · NA · recruiting
- NCT06314581 — Effect of a Multifaceted Educational Intervention on the Implementation of Evidence-based Practices for Benign Paroxysma · active not recruiting
- NCT05834452 — Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair. · NA · active not recruiting
Other Neuro Counsel Hospital, Pakistan trials
Trials by the same sponsor.
- NCT06098053 — Efficacy of Muscle Energy Technique Alone and in Combination With Interferential Therapy for the Treatment of Non-specif · NA · completed
- NCT06056076 — Comparison of Mini Squat and Endurance Training in Improving Quality of Life in Knee Osteoarthritis · NA · completed
- NCT06031857 — Comparison of Kinesio Tape and Dry Needling for the Management of Rotator Cuff Tendinopathy: A Randomized Control Trial · NA · completed
- NCT05884567 — Effectiveness of Neck Isometric Exercises and Cervical Mobilization on Cervical Radiculopathy · NA · completed
- NCT05871944 — Effectiveness of Kaltenborn End Range Joint Mobilization Technique and Post FacilitationStretch in Shoulder Impingement · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05309538 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuro Counsel Hospital, Pakistan
- Last refreshed: 4 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05309538.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing